News and developments

Press Releases

GSK Stockmann advised Eleving Group on the completion of the largest IPO of a privately held company in Latvia

GSK Stockmann advised the fintech company Eleving Group on the completion of the largest offer of shares by way of an initial public offering (IPO) of a privately held company in Latvia and subsequent listing and trading of the offered shares on the Nasdaq Baltic Main List and Frankfurt Stock Exchange’s regulated market Prime Standard. With the IPO, Eleving Group aims to offer investors an opportunity to invest in one of the fastest growing, Baltic-headquartered, and Luxembourg-domiciled fintech companies operating in vehicle and consumer financing segments across 16 markets and three continents.
26 March 2025
Press Releases

GSK Stockmann appoints seven new partners and two counsel from within its own ranks

At the Partners’ Meeting on 24 and 25 November 2023, GSK Stockmann appointed four new Equity Partners, three Local Partners and two Counsel from within its own ranks with effect from 1 January 2024. These promotions reflect the firm’s unwavering commitment to its strategy of supporting the professional development of its young lawyers and deploying their talents to build up its strategic advisory fields.
22 March 2024
Press Releases

GSK Stockmann advises FONDSGRUND on the acquisition of the 28,500 sqm “Netzwerk” property in Regensburg for an HIH Invest fund

A GSK Stockmann team led by Michael Jani provided comprehensive advice on real estate, tax, investment and insurance law to the Hamburg-based investment and asset manager FONDSGRUND Investment in connection with the acquisition of the “Netzwerk” office property in Regensburg for HIH Invest Real Estate and a club of German institutional investors.
21 March 2024
Press Releases

GSK Stockmann berät Unstoppable Finance bei Serie-A-Finanzierungsrunde

GSK Stockmann hat die in Berlin ansässige Unstoppable Finance GmbH bei ihrer aktuellsten Finanzierungsrunde beraten. Das Krypto-Start-up hat 12,5 Millionen Euro eingeworben und die US-Risikokapitalgesellschaft Lightspeed Venture Partners in den Kreis seiner namhaften Investoren aufgenommen. Bestehende Geldgeber wie Speedinvest und Discovery Ventures sowie der Rockaway Blockchain Fund haben sich ebenfalls an der Finanzierungsrunde beteiligt.
02 September 2022
GSK Stockmann